Mohammad Afkhami‐Ardekani

1.3k citations
50 papers · 1.0k indexed · h-index 15
Topics
Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers)Natural Antidiabetic Agents Studies (6 papers)Diabetes Management and Education (5 papers)
Journals
SHILAP Revista de lepidopterologíaDiabetes CareThe Journal of Alternative and Complementary Medicine
Partner nations
IranAustraliaHungary

In The Last Decade

Mohammad Afkhami‐Ardekani

47 papers receiving 947 citations

Peers

Mohammad Afkhami‐Ardekani
Comparison fields: 5 of 108
  • Endocrinology, Diabetes and Metabolism 250
  • Public Health, Environmental and Occupational Health 231
  • Ophthalmology 149
  • Pharmacology 133
  • Nutrition and Dietetics 119
Replace Yaping Jiang with:
Yaping Jiang China
Farin Rashid Farokhi Iran
Giovanni Sartore Italy
Aida Malek Mahdavi Iran
Spyridon Papaioannou Greece
Orkide Donma Türkiye
Rajagopal V. Sekhar United States
Zahra Kashi Iran
Emina Čolak Serbia
Ömer Çolak Türkiye
Mohammad Afkhami‐Ardekani relative to Yaping Jiang China Yaping Jiang's profile →
Citations per field
00.5×6.8×
Yaping Jiang · 1×
Citations per year

Countries citing papers authored by Mohammad Afkhami‐Ardekani

Since Specialization
Citations

This map shows the geographic impact of Mohammad Afkhami‐Ardekani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Afkhami‐Ardekani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Afkhami‐Ardekani more than expected).

Fields of papers citing papers by Mohammad Afkhami‐Ardekani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Afkhami‐Ardekani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Afkhami‐Ardekani. The network helps show where Mohammad Afkhami‐Ardekani may publish in the future.

Co-authorship network of co-authors of Mohammad Afkhami‐Ardekani

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Afkhami‐Ardekani. A scholar is included among the top collaborators of Mohammad Afkhami‐Ardekani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Afkhami‐Ardekani. Mohammad Afkhami‐Ardekani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1
The Comparison of Tooth Pulp Electrical Threshold in Patients with Type II Uncontrolled Diabetes and Healthy Subject
5
2
Effect of Oral Supplementation of L-arginine on Sexual Function in Men with Type 2 Diabetes: A Double-blind Clinical Trial
9
3
The Relationship between Frequency of Restless leg Syndrome and Type 2 diabetes
0
4
Melia Azedarach L. Fruit Extract Effect on Plasma Lipid Profile and Cardiac and Hepatic Functions of Diabetic Rats
0
5
Frequency Distribution of Intestinal Parasitic Infections in Diabetic Patients–Yazd 2013
9
6
Evaluation of Sexual Function in Men with Diabetes Mellitus Type 2- Yazd Diabetes Research Center
4
7
Comparison of the Unstimulated whole Saliva Flow Rate in Diabetic Type II Patients with Healthy Individuals
2
8
Prevalence of Aspirin Use among Type 2 Diabetic Patients in Iran
1
9
Prevalence of Obesity and Overweight among Adults in Iranian Population (Yazd Province)
11
10
Foot Care in Diabetic Patients, Based on Health Belief Model in Yazd – Iran (2009)
1
11
Comparison of Sour and Black Tea Consumption on the Serum Lipid Oxidizability in Diabetic Patients
1
12 60
13
Prevalence of Type 2 Diabetes Complications and their Contributing Factors in Yazd Province
6
14
Effect of Vitamin E on Blood Glucose, Lipid Profile and Blood Pressure in Type 2 Diabetic Patients
7
15
Evaluation of Thyroid Autoantibodies in Type 2 Diabetes
3
16
COMPARISON OF THE EFFECTS OF SODIUM METAVANADATE AND ZINC SULFATE SUPPLEMENTATION ON LIPID AND GLUCOSE IN PATIENTS WITH TYPE 2 DIABETES
6
17 6
18
EFFECT OF VITAMIN E ON GLYCEMIC CONTROL AND LIPID PROFILE IN TYPE 2 DIABETES
1
19 76
20 54

About Mohammad Afkhami‐Ardekani

Mohammad Afkhami‐Ardekani is a scholar working on Endocrinology, Diabetes and Metabolism, Ophthalmology and Biochemistry, having authored 50 papers that have together received 1.0k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers), Natural Antidiabetic Agents Studies (6 papers) and Diabetes Management and Education (5 papers). The work is most often cited by research in Ophthalmology (149 citations), Pharmacology (133 citations) and Endocrinology, Diabetes and Metabolism (250 citations). Mohammad Afkhami‐Ardekani has collaborated with scholars based in Iran, Australia and Hungary. Frequent co-authors include Maryam Rashidi, Ahmad Shojaoddiny-Ardekani, Masoud Reza Manaviat, M R Shoja, Hassan Mozaffari–Khosravi, Farhad Fatehi, Mahmood Noorishadkam, Elham Amirchaghmaghi, Akram Ghadiri‐Anari and Sedigheh Soheilykhah. Their work appears in journals such as SHILAP Revista de lepidopterología, Diabetes Care and The Journal of Alternative and Complementary Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026